Placebo + Viagra (sildenafil citrate)
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Impotence
Conditions
Impotence
Trial Timeline
Jul 1, 2006 → Sep 1, 2007
NCT ID
NCT00343200About Placebo + Viagra (sildenafil citrate)
Placebo + Viagra (sildenafil citrate) is a approved stage product being developed by Pfizer for Impotence. The current trial status is completed. This product is registered under clinical trial identifier NCT00343200. Target conditions include Impotence.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00343200 | Approved | Completed |
Competing Products
20 competing products in Impotence
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| tadalafil | Eli Lilly | Approved | 85 |
| tadalafil + sildenafil | Eli Lilly | Approved | 85 |
| tadalafil + placebo + tadalafil + tadalafil + tadalafil + placebo | Eli Lilly | Phase 3 | 77 |
| GPI 1485 | Eisai | Phase 2 | 52 |
| tadalafil + sildenafil | Eli Lilly | Approved | 85 |
| tadalafil | Eli Lilly | Approved | 85 |
| tadalafil + sildenafil | Eli Lilly | Phase 3 | 77 |
| tadalafil | Eli Lilly | Phase 3 | 77 |
| tadalafil + placebo + tadalafil + tadalafil | Eli Lilly | Phase 3 | 77 |
| tadalafil + Placebo | Eli Lilly | Phase 3 | 77 |
| tadalafil + tadalafil + placebo | Eli Lilly | Phase 3 | 77 |
| tadalafil + tadalafil + placebo | Eli Lilly | Phase 3 | 77 |
| Fluvastatin-sodium | Novartis | Phase 3 | 77 |
| Sildenafil Citrate | Pfizer | Approved | 84 |
| UK0369,003 + Cialis (Tadalafil) | Pfizer | Phase 2 | 51 |
| Viagra (Sildenafil citrate) | Pfizer | Approved | 84 |
| sildenafil citrate | Pfizer | Approved | 84 |
| UK-369,003 | Pfizer | Phase 2 | 51 |
| Viagra (Sildenafil Citrate) 100 mg | Pfizer | Approved | 84 |
| Viagra (Sildenafil citrate) | Pfizer | Approved | 84 |